Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MART-1 Antigen | 1 | 2018 | 62 | 0.610 |
Why?
|
| MicroRNAs | 5 | 2017 | 3788 | 0.570 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2018 | 199 | 0.560 |
Why?
|
| Nevus, Pigmented | 1 | 2018 | 222 | 0.510 |
Why?
|
| SOXC Transcription Factors | 1 | 2015 | 42 | 0.500 |
Why?
|
| Liposomes | 1 | 2016 | 786 | 0.400 |
Why?
|
| Immunomodulation | 1 | 2016 | 548 | 0.390 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2018 | 3405 | 0.370 |
Why?
|
| Hematopoiesis | 3 | 2015 | 2060 | 0.360 |
Why?
|
| Immune System | 1 | 2016 | 799 | 0.350 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2023 | 1759 | 0.350 |
Why?
|
| Molecular Imaging | 1 | 2016 | 822 | 0.330 |
Why?
|
| Image Enhancement | 2 | 2018 | 2857 | 0.330 |
Why?
|
| Bone Marrow Cells | 2 | 2015 | 2411 | 0.300 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1623 | 0.290 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2023 | 5333 | 0.280 |
Why?
|
| Gene Expression Regulation | 4 | 2022 | 11895 | 0.280 |
Why?
|
| Contrast Media | 2 | 2018 | 5330 | 0.270 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4394 | 0.250 |
Why?
|
| Nanoparticles | 1 | 2016 | 1966 | 0.240 |
Why?
|
| Pancreatic Neoplasms | 4 | 2023 | 5450 | 0.220 |
Why?
|
| Melanoma | 2 | 2023 | 5695 | 0.220 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 3940 | 0.220 |
Why?
|
| B-Lymphocytes | 2 | 2015 | 4782 | 0.210 |
Why?
|
| Stomach Neoplasms | 2 | 2024 | 1469 | 0.200 |
Why?
|
| Immune Evasion | 2 | 2023 | 376 | 0.200 |
Why?
|
| Dioxygenases | 1 | 2024 | 354 | 0.190 |
Why?
|
| Neoplasms | 3 | 2024 | 22340 | 0.180 |
Why?
|
| Giant Cell Arteritis | 1 | 2024 | 308 | 0.160 |
Why?
|
| Endothelium | 1 | 2022 | 768 | 0.160 |
Why?
|
| Cell Differentiation | 5 | 2018 | 11639 | 0.160 |
Why?
|
| Pulmonary Alveoli | 1 | 2022 | 665 | 0.160 |
Why?
|
| P-Selectin | 1 | 2021 | 598 | 0.160 |
Why?
|
| Myeloid Cells | 4 | 2021 | 838 | 0.160 |
Why?
|
| Brain Neoplasms | 2 | 2018 | 9065 | 0.160 |
Why?
|
| Viremia | 1 | 2021 | 727 | 0.150 |
Why?
|
| Cell Dedifferentiation | 1 | 2018 | 125 | 0.140 |
Why?
|
| Interferons | 1 | 2020 | 714 | 0.140 |
Why?
|
| Cell Survival | 2 | 2015 | 5745 | 0.120 |
Why?
|
| Leukemia, B-Cell | 1 | 2015 | 86 | 0.120 |
Why?
|
| Leukemia, Experimental | 1 | 2015 | 224 | 0.120 |
Why?
|
| Immunotherapy | 4 | 2024 | 4746 | 0.120 |
Why?
|
| Thromboembolism | 1 | 2021 | 1001 | 0.120 |
Why?
|
| Stem Cell Factor | 1 | 2015 | 194 | 0.120 |
Why?
|
| Coculture Techniques | 1 | 2018 | 1336 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2024 | 11858 | 0.110 |
Why?
|
| Glioblastoma | 2 | 2018 | 3458 | 0.110 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 514 | 0.110 |
Why?
|
| Adenocarcinoma | 2 | 2021 | 6360 | 0.110 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 1009 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 6 | 2018 | 22327 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2018 | 1888 | 0.100 |
Why?
|
| Multipotent Stem Cells | 1 | 2014 | 200 | 0.100 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 6958 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 4641 | 0.100 |
Why?
|
| Multigene Family | 1 | 2015 | 1081 | 0.100 |
Why?
|
| Animals | 10 | 2024 | 168735 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2017 | 14450 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2018 | 1475 | 0.100 |
Why?
|
| NF-kappa B | 2 | 2017 | 2492 | 0.090 |
Why?
|
| Models, Biological | 3 | 2022 | 9443 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 733 | 0.090 |
Why?
|
| Humans | 31 | 2024 | 765926 | 0.090 |
Why?
|
| Phenotype | 3 | 2024 | 16714 | 0.090 |
Why?
|
| Mice | 6 | 2024 | 81782 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2021 | 2100 | 0.090 |
Why?
|
| HEK293 Cells | 2 | 2017 | 4257 | 0.080 |
Why?
|
| Apoptosis | 2 | 2015 | 9505 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 1787 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2020 | 2515 | 0.080 |
Why?
|
| Periplasmic Binding Proteins | 1 | 2008 | 34 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 2795 | 0.080 |
Why?
|
| Gallium | 1 | 2008 | 30 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 1504 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2021 | 2818 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2016 | 1354 | 0.070 |
Why?
|
| Aging | 2 | 2018 | 8725 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 7599 | 0.070 |
Why?
|
| Iron-Binding Proteins | 1 | 2008 | 83 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2018 | 2969 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4882 | 0.070 |
Why?
|
| Renin-Angiotensin System | 2 | 2022 | 736 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2603 | 0.070 |
Why?
|
| Macrophages | 2 | 2020 | 5772 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1404 | 0.070 |
Why?
|
| Ferric Compounds | 1 | 2008 | 367 | 0.070 |
Why?
|
| Recurrence | 1 | 2018 | 8492 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3816 | 0.060 |
Why?
|
| Homeostasis | 1 | 2016 | 3338 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2023 | 3158 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3078 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 1882 | 0.050 |
Why?
|
| Toll-Like Receptors | 2 | 2018 | 582 | 0.050 |
Why?
|
| Tumor Necrosis Factors | 1 | 2023 | 109 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5752 | 0.050 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2022 | 37 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2022 | 12129 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 9541 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2024 | 23597 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 189 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 10046 | 0.050 |
Why?
|
| Angiotensins | 1 | 2022 | 139 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 253 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 17060 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 10810 | 0.050 |
Why?
|
| Cell Line | 1 | 2015 | 15540 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 10256 | 0.050 |
Why?
|
| Spheroids, Cellular | 1 | 2023 | 329 | 0.050 |
Why?
|
| Platinum | 1 | 2022 | 219 | 0.040 |
Why?
|
| Surface-Active Agents | 1 | 2020 | 150 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2023 | 384 | 0.040 |
Why?
|
| Middle Aged | 8 | 2024 | 223016 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 1927 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 634 | 0.040 |
Why?
|
| Renin | 1 | 2022 | 647 | 0.040 |
Why?
|
| Vasopressins | 1 | 2021 | 359 | 0.040 |
Why?
|
| Chemokines | 1 | 2024 | 956 | 0.040 |
Why?
|
| Caspases | 1 | 2023 | 880 | 0.040 |
Why?
|
| Prognosis | 4 | 2022 | 29890 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 13446 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2021 | 784 | 0.040 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2020 | 308 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2024 | 1648 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10843 | 0.040 |
Why?
|
| Cytokines | 1 | 2014 | 7417 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 992 | 0.040 |
Why?
|
| Male | 10 | 2024 | 363815 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2023 | 886 | 0.040 |
Why?
|
| Mucins | 1 | 2020 | 568 | 0.040 |
Why?
|
| Pyridones | 1 | 2023 | 816 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2021 | 502 | 0.040 |
Why?
|
| Autopsy | 1 | 2020 | 1011 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2020 | 1885 | 0.030 |
Why?
|
| Organoids | 1 | 2023 | 740 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2022 | 1362 | 0.030 |
Why?
|
| Standard of Care | 1 | 2020 | 568 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 839 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2020 | 824 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 36547 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2020 | 1777 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2021 | 1491 | 0.030 |
Why?
|
| Immunity | 1 | 2020 | 1000 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2018 | 1524 | 0.030 |
Why?
|
| Aged | 6 | 2024 | 171163 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2018 | 1072 | 0.030 |
Why?
|
| Survival Rate | 2 | 2018 | 12822 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2022 | 1748 | 0.030 |
Why?
|
| Pancreas | 1 | 2020 | 1698 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15878 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 20690 | 0.030 |
Why?
|
| Female | 9 | 2024 | 396141 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2053 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2021 | 1590 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 3542 | 0.020 |
Why?
|
| Ligands | 1 | 2018 | 3272 | 0.020 |
Why?
|
| Viral Load | 1 | 2020 | 3385 | 0.020 |
Why?
|
| Proteome | 1 | 2021 | 1896 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 2895 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 59496 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 4555 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 2726 | 0.020 |
Why?
|
| Neutrophils | 1 | 2022 | 3769 | 0.020 |
Why?
|
| Brain | 1 | 2016 | 27179 | 0.020 |
Why?
|
| Adult | 5 | 2022 | 223088 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2024 | 3458 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 2012 | 695 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2022 | 6251 | 0.020 |
Why?
|
| Mutation | 2 | 2024 | 30192 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3684 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2012 | 657 | 0.020 |
Why?
|
| Critical Illness | 1 | 2021 | 2749 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2661 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2008 | 199 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8724 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 1823 | 0.020 |
Why?
|
| Haemophilus influenzae | 1 | 2008 | 177 | 0.020 |
Why?
|
| Proteomics | 1 | 2021 | 3906 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 11030 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 39228 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2018 | 3560 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2024 | 9600 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2008 | 577 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10575 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5691 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9525 | 0.020 |
Why?
|
| Genomics | 1 | 2022 | 5925 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 3238 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2023 | 65194 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11196 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 13026 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12417 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 8037 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3599 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2012 | 2916 | 0.010 |
Why?
|
| Adolescent | 2 | 2021 | 88811 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2008 | 1970 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8721 | 0.010 |
Why?
|
| Kinetics | 1 | 2008 | 6273 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 18074 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41680 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 18962 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 54807 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 40097 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74850 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14643 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 59857 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 81537 | 0.010 |
Why?
|
Concepts
(207)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(122)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore